Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-30

Clinical Trial Update: Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating dose-escalated stereotactic ablative radiotherapy (SABR) for metastases in the spine from solid tumors, and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Solid Tumor Spine Metastases | Phase 1, Phase 2 | Status: RECRUITING